1.1
Eltrombopag is recommended as an option for treating chronic immune thrombocytopenia in adults, only if:
-
their condition is refractory to standard active treatments and rescue therapies or
-
they have severe disease and a high risk of bleeding that needs frequent courses of rescue therapies.
Eltrombopag is recommended only if the company provides it with the discount agreed in the patient access scheme.